Lung Cancer
Lung CANCER
A simple blood test to identify people with a heightened risk of lung cancer for triage into CT scanning.
EGFR
EGFR mutation testing works to detect mutations in the EGFR gene within the DNA of the tumour cells. This assists clinicians to determine whether someone with non-small cell lung cancer may benefit from targeted therapy with tyrosine kinase inhibitors.
PD-L1
Testing is available to clinicians in order to guide treatment options in immunotherapy.
ALK FISH & ROS-1 FISH
Looking at the ALK and ROS1 genes - helping to determine whether a person with non-small cell lung cancer will respond to a targeted drug therapy.
RET
Analysing the RET gene to help determine whether a person with non-small cell lung cancer will respond to a targeted drug therapy.
KRAS
Looking at the KRAS gene especially G12C mutation- helping to determine whether a person with non-small cell lung cancer will respond to a targeted drug therapy.
Further information
For more detail on screening and early cancer detection, please visit our Cancer Testing page.
For more detail on tests to investigate cancer aggressiveness or to guide treatment, please visit the Companion Diagnostics page.
USEFUL DOWNLOADS
ACCESS
If you are a healthcare professional, please contact us. If you are a patient, please refer your healthcare professional to our website and ask them to get in touch. Please note that Cambridge Clinical Laboratories HCP services are only available through a professional healthcare provider.
If you would like to use one of these services, please contact us.